Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Not yet recruiting 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 5Triple Negative Breast Neoplasms 2Vaccinia 1Solid Tumors 1Pathologic Complete Response 1Ovarian Neoplasms 1Neoplasm Metastasis 1Gastric Adenocarcinoma 1Fallopian Tube Neoplasms 1Breast Diseases 1Anatomic Stage IV Breast Cancer AJCC v8 1

Interventions

Magnetic Resonance Spectroscopy 5Specimen Handling 4Biopsy 3Steroids 2Hormones 2Cyclin-Dependent Kinase Inhibitor p18 2Cyclin-Dependent Kinase Inhibitor p16 2trastuzumab deruxtecan 1trastuzumab biosimilar HLX02 1taxane 1radium Ra 223 dichloride 1pertuzumab 1naxitamab 1eicosapentaenoic acid ethyl ester 1eicosapentaenoic acid ethanolamide 1binimetinib 1abemaciclib 1X-Rays 1Trastuzumab 1Taxoids 1Taxes 1Radiotherapy 1Radiosurgery 1Radiation 1Photons 1Paclitaxel 1PF-05280014 1Ontruzant 1Ogivri 1Mastectomy, Simple 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Anatomic Stage IV Breast Cancer AJCC v8 × taxane × 1 year × Clear all
NCT07578116 2026-05-27

Adding Surgery and Radiation to the Usual Treatment for HER2-Positive Breast Cancer That Had Already Spread at Diagnosis

SWOG Cancer Research Network

Phase 3 Not yet recruiting
562 enrolled
Breast

Anatomic Stage IV Breast Cancer AJCC v8

Data powered by HemOnc (CC BY 4.0) Colophon âš¡